Role of Oxidative Strees and Antioxidants in Obese and non-obese womans with Polycystic Ovary Syndrome
Main Article Content
Abstract
The study was conducted on (90) blood samples, 60 samples from patients with (PCOS) and 30 of them were healthy women. Blood samples were collected from women attending outpatient clinics in Kirkuk Governorate, after their diagnosis. By obstetrics and gynecologists for the period from 11/20/2021 to 25/2/2022, as their ages ranged between (17-42) years, and they were divided into three groups depending on the body mass index (BMI), the first group (30) samples for patients with (PCOS) who are obese with BMI of more than 30 kg/m2 , and second group (30) samples for ladies without obesity who have polycystic ovary syndrome with a BMI of less than 25 kg / m2 and the third group (30) samples of non-infected women with a BMI of more than 30 kg / m2 as a control group. The study included the measurement of antioxidants, including non-enzymatic antioxidants It includes (glutathione, uric acid, and bilirubin), as well as measuring the concentration of malondialdehyde in obese, and without obesity (PCOS).
The findings of this researh show following:
* Increase that is statistically significant (P ≤0.01) in the concentration malondialdehyde when comparing obese women with PCOS with control, and increase that is statistically significant (P ≤0.05) when comparing between PCOS-afflicted obese and non-obese women
* A notable reduction in the p-valu (P≤0.01) in the (bilirubin and glutathione) of concentration when comparing obese PCOS patients with control, a notable reduction and at the level of probability (P≤0.01) in the concentration of bilirubin and (P≤0.05) in the concentration of glutathione at Comparing obese women with PCOS to non-obese patients.
* A notable reduction (P≤0.05) in the total capacity of antioxidants in obese women with PCOS compared with the control group, the results showed decrease that is statistically significant (P ≤0.01) when comparing the concentration of the total capacity of antioxidants between women Obese and non-obese patients.
* A non-significant differences in uric acid concentration when comparing women with PCOS with control, and the results showed a increase that is statistically significant (P ≤0.05) when comparing women with PCOS who are obese with those who are not obese.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Guyton,A.C.and Hall,J.E.(2006). Text book of medical physiology 11th Ed. Philadelphia 5th ed .pp: 1014-1019.
II. Studying of Metal elements, Urea and Creatinine in Cerebrospinal Fluid for Children with Hydrocephalus PatientsLelas Farhan Bdaiwi ,Sayran Sattar Saleh , Luay Abed Al-HelalyKirkuk University Journal-Scientific Studies, 2018, Volume 13, Issue 2, Pages 214-229
III. Deepika,M.L.N.,S.Nalini,G.Maruthi,Vinish Rarnch and, K.Ranjith, K.Prasanna Latha, V.Usha Rani and P.Jahan.(2014),Analysis of Oxidative Stress status through MN test and serum MDA Levels in PCOS women ,Pakistan journal of biological scienccs 17(4):574 -577.
IV. Moore, K. L., Persaud, T. V. N. and Torchia, M. G. (2015). ―Before We Are Born‖ 9th ed., E-Book: Essentials of Embryology and Birth Defects With Student Consult Online Access. Elsevier Health Sciences.
V. Benzie, I. F. and Strain, J. J(1996). The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power : the FRAP assay. Analytical biochemistry.; 239(1): 70-76.
VI. Shah, J. K. and Walker's, A. M(1989). Quantitative determination of MDA. Biochemica et Biophysica Acta.; 11: 207-211.
VII. Aziz BN,AL-Kataan MA, Ali WK.(2017). Lipid peroxidation and antioxidant status in β –thalassemic patients : effect of iron overload .Iraqi J Pharm Sci;18(2):1-7 .
VIII. Fossati, P., PRENCIPE L.,and BERTI G.,(1980) Use of 3,5-dichloro-2-Hydroxybenzene silfonic acid /4Aminophenazone chromogenic systeme in direct enzymatic assays of uric acid in serum and urin ,Clin. Chem.:26(227-231)
IX. Tietz,N. (1999). Textbook of clinical chemistry. 3reded. C.A. Burtis, E.R. Ashwood, W.B. Saunders.Pp:826-835.
X. Zimmer, K.P., Fischer, I., Mothes, T., Weissen-Plenz, G., Schmitz, M., Wieser, H., Büning, J., Lerch, M.M., Ciclitira, P.C and Weber, P. (2010).Endocytotic segregation of gliadin peptide 31–49 in enterocytes, 59, 300–310.
XI. Rasool, M, R. A., Rizwan, R., Malik, A., Asif, M., Zaheer, A., Jabbar, A. and Jamal12, M. S. (2018). Inter-relationship of circulating biochemical markers of oxidative stress and comorbid condition in polycystic ovary syndrome. Biomedical Research, 29(21), 3779-3783.
XII. Uçkan, K., Demir, H., Turan, K., Sarıkaya, E., and Demir, C. (2022). Role of oxidative stress in obese and nonobese PCOS patients. International Journal of Clinical Practice, 2022.
XIII. Luberda, Z. (2005). The role of glutathione in mammalian gametes. Reprod Biol .5(1),-17
XIV. Zuelke, K. A.; Jeffay, S. C. ; Zucker, R. M. ; Perreault, S. D. (2003). Glutathione (GSH) concentrations vary with the cell cycle in maturing hamster oocytes, zygotes, and pre-implantation stage embryos. Mol. Reprod. Dev. 64(1), 106–112.
XV. Rizzo, A. M. ; Berselli, P.; Zava, S.; Montorfano, G.; Negroni M.; Corsetto P.; Berra, B. (2010). Endogenous antioxidants and radical scavengers. Adv. Exp. Med. Biol. 698, 52-67.
XVI. Yang, H., Di, J., Pan, J., Yu, R., Teng, Y., Cai, Z. and Deng, X. (2020). The association between prolactin and metabolic parameters in PCOS women: A retrospective analysis. Frontiers in endocrinology, 11, 263.
XVII. 17- Hu X, Rong S, Wang Q,Sun T. Bao W,Chen L, et al(2021). Association Between PlasmamUric Acid and Insulin Resistance in Type2 Diabetes : A Mendelian Randomization Analysis. Diabetes Res Clin Pract 171:108542.
XVIII. Ighodaro, O. M. and Akinloye, O. A. (2018). First line defence antioxidantssuperoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria journal of medicine, 54(4), 287-293.
XIX. Masjedi, F., Keshtgar, S., Agah, F. and Karbalaei, N. (2019). Association between sex steroids and oxidative status with vitamin D levels in follicular fluid of non-obese PCOS and healthy women. Journal of Reproduction and Infertility, 20(3), 132.
XX. Cabello-Verrugio, C., Ruiz-Ortega, M., Mosqueira, M. and Simon,F.(2016). Oxidative stress in disease and aging: mechanisms and therapies Oxidative Med and Cell Longevity, vol. Article ID 8786564,pp:2.
XXI. Nasiri, N., Moini, A., Eftekhari-Yazdi, P., Karimian, L., Salman-Yazdi, R., Zolfaghari, Z. and Arabipoor, A. (2015). Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome. European Journal of Obstetrics and Gynecology and Reproductive Biology, 184, 112-116.